CKMM

CKMM Full Name

Creatine Kinase MM

CKMM Introduction

Creatine Kinase MM (CKMM), also referred to as creatine kinase, muscle type (MCK), is the musclespecific cytosolic isoenzyme of the creatine kinase family encoded by the CKM gene on human chromosome 19q13.3. CKMM is comprised of two identical Msubunits forming a homodimer that predominates in striated skeletal muscle and makes up the vast majority of total CK activity in these tissues, while it also contributes significantly to CK in cardiac muscle as part of energy metabolism in muscle fibers. As a key component of cellular energy homeostasis, CKMM catalyzes the reversible transfer of a highenergy phosphate group between ATP and creatine phosphate (phosphocreatine), effectively buffering and regenerating ATP during periods of rapid energy demand such as muscle contraction. This enzymatic activity places CKMM at the heart of muscle physiology, ensuring efficient energy transport and utilization in tissues with high and fluctuating energy needs.

Figure 1. Signaling pathway diagram of CKMM in muscle homeostasis and disease.

Functionally, CKMM serves as an ATPregenerating system that supports the energetic requirements of muscle contraction and relaxation by maintaining local ATP levels near myofibrillar ATPases and other ATPdependent processes. In skeletal muscle cells, CKMM is strategically located in the cytosol and interacts with structural proteins at the sarcomeric Mband, facilitating close coupling of energy production to consumption sites within the contractile apparatus. This spatial organization enhances the efficiency of the phosphocreatine shuttle, which transfers phosphate groups from mitochondrially produced phosphocreatine to ADP to rapidly replenish ATP during intense physical activity. Because CKMM is so integral to muscle energetics and structure, it has become a valuable research target in studies of muscle physiology, enzyme kinetics, and energy metabolism, with numerous antibodies, activity assays, recombinant proteins, and other reagents available to probe its function in normal and experimental settings.

Clinically, elevated levels of CKMM in blood are widely used as a biomarker of skeletal muscle damage and are measured in both diagnostic and research contexts to assess muscle injury or pathology. Conditions such as muscular dystrophies, polymyositis, dermatomyositis, rhabdomyolysis, strenuous exercise, and statininduced myopathies can release CKMM into circulation as muscle membranes become compromised, leading to detectable increases in serum CK activity. In contrast, because CKMM is also present in cardiac muscle (often as part of the CKMB heterodimer), its relative contribution to total CK can help differentiate sources of tissue damage, although modern cardiac biomarkers like troponins have largely supplanted CKMM for acute myocardial infarction diagnosis. Genetic variation in the CKM gene may also affect individual responses to exercise and susceptibility to muscle disorders, underscoring the complexity of CKMM regulation in health and disease.

Alternate Names for CKMM

Creatine kinase-M; creatine kinase M chain; EC 2.7.3.2; CKM; CKMM; Creatine kinase M; Creatine kinase M type; Creatine kinase M-type; Creatine kinase muscle; KCRM_HUMAN; M CK; M-CK; MCK; MS785; Muscle creatine kinase

• 1. Nakamura Y, et al.; Elevation in creatine kinase isoenzyme-MM associated with hepatocellular carcinoma: a case report and review of literature. Clin J Gastroenterol. 2022, 15(2):460-466.
  2. Wu AH. Creatine kinase isoforms in ischemic heart disease. Clin Chem. 1989, 35(1):7-13.